Your browser doesn't support javascript.
loading
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine.
Conway, Jake R; Kofman, Eric; Mo, Shirley S; Elmarakeby, Haitham; Van Allen, Eliezer.
Afiliação
  • Conway JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Kofman E; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, 02142, USA.
  • Mo SS; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02215, USA.
  • Elmarakeby H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Van Allen E; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, 02142, USA.
Genome Med ; 10(1): 93, 2018 11 29.
Article em En | MEDLINE | ID: mdl-30497521
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article